Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; R factor = 0.030; wR factor = 0.065; data-to-parameter ratio = 19.0.
In the title compound, C 30 H 29 BrN 2 O 5 , the -lactam ring is essentially planar, with the O atom displaced from this plane by 0.856 (9) Å , and forming dihedral angles of 24.35 (13) and 89.42 (14) with the planes of the benzene substituent groups on this ring. The tetrahydropyran ring adopts an envelope conformation with the C atom bearing the -lactam ring as the flap. In the crystal, weak C-HÁ Á ÁO hydrogen bonds with carboxyl and tetrahydropyran O-atom acceptors give rise to a chain structure extending along the b-axis direction.
Related literature
For general background to -lactams, see: Brakhage (1998). For a related structure, see: Sundaramoorthy et al. (2012) . For conformation of the molecular structure, see: Nardelli (1983) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Comment
The most commonly used β-lactam antibiotics for the therapy of infectious diseases are penicillin and cephalosporin (Brakhage, 1998) . In view of potential applications, the crystal structure determination of the title β-lactam derivative, C 30 H 29 BrN 2 O 5 , was carried out and is reported herein. In this compound (Fig. 1) , the four-membered ring of the β-lactam fragment (N2/C1-C3) is essentially planar (r.m.s. deviation = 0.0122 Å), with O1 displaced from the plane by 0.856 (9) Å. The mean-planes of the benzene rings of the two benzene substituent groups defined by C4-C9 and C10-C15 are inclined at dihedral angles 24.35 (13)° and 89.42 (14) °, respectively, with respect to four-membered β-lactam ring. The pyrrolidine ring (N1/C16/C17/C18/C19) adopts an envelope conformation, defined by the asymmetry parameters (Nardelli, 1983) , DS (N2) = 0.0789 (19) Å and D2 (C16) = 0.0228 (15) Å whereas the pyran ring [(O5/C18/C19/C20/C21/C22) adopts a C19-envelope/sofa conformation with C19 displaced by 0.385 (1) Å from the least-squares planes formed by the remaining ring atoms.
In the crystal, the structure is stabilized by weak intermolecular aromatic C14-H···O5 tetrahydropyran and tetrahydropyran C20-H···O4 carboxyl hydrogen-bonding interactions (Table 1) , giving a one-dimensional chain extending along b (Fig. 2) .
Present also in the structure are two intramolecular C-H···β-lactam interactions involving aromatic C11-H11···Cg 
Experimental
A solution of (Z)-methyl 2-[(4-bromo-2-formylphenoxy)methyl]-3-[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin-2-yl]acrylate (1 mmol) and sarcosine (1.2 mmol) was refluxed in dry acetonitrile. Completion of the reaction was confirmed by TLC analysis. The solvent was then removed under vacuum, then diluted with dichloromethane and washed with brine and water. The organic layer was separated and removed and the residue was subjected to column chromatography using ethyl acetate and hexane (2:8) as an eluent, affording the cycloadduct. The product was dissolved in ethyl acetate and the resulting solution was allowed to slowly evaporate over 48 h, resulting in the formation of crystals suitable for the single-crystal X-ray diffraction analysis.
Refinement
Hydrogen atoms were included at calculated positions with C-H ranging from 0.93 to 0.97 Å and treated using a riding model with displacement parameters U iso (H) = 1.2U eq (C)(methine, methylene and aromatic), or 1.5U eq (C)(methyl). The absolute configuration for the molecule was not determined definitively but the local configuration for the five chiral 
Figure 1
The molecular configuration and atom numbering for the title compound, with displacement ellipsoids drawn at the 30% probability level. 
